PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if the pharmacokinetic profile of V1512 is similar
or better than existing medications for the treatment of Parkinson's Disease
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vernalis (R&D) Ltd
Collaborators:
Cita NeuroPharmaceuticals INC Research Syneos Health